UK ban on adverts for ‘unhealthy’ food comes into effect in bid to tackle obesity The government estimates the advertising ban will prevent around 20,000 cases of childhood obesity The Independent UK · Jan 5
Ban on adverts for ‘less healthy food’ set to come into full effect They will not be allowed to appear on television between 5.30am and 9pm, or online at any time. Evening Standard · Jan 4
New crackdown on ads for ‘less healthy food’ to come into full effect The ban applies to products that fall within 13 categories considered to play the most significant role in childhood obesity The Independent UK · Jan 4
The WHO learned to love ‘anti-obesity’ jabs in 2025. I don’t fully agree, but I get it While GLP-1 drugs promise an easy fix, our bodies still need what they have always needed: healthy food and regular exercise, says chair of global public health at the University of Edinburgh, Prof Devi Sridhar The Guardian - UK · Dec 31, 2025
This Small But Mighty Stock Could Surprise Investors in 2026 This under-the-radar biotech stock is setting up for a big 2026. Barchart · Dec 29, 2025
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now? Barchart · Dec 25, 2025
Sleds over screens: Why it’s time to limit your children’s screen time this Christmas Heavy use of phones, tablets and gaming consoles has been linked to anxiety, depression, poor attention and even obesity. Euronews · Dec 24, 2025
US approves pill version of blockbuster weight-loss drug Wegovy Availability of oral pills to treat obesity could expand the booming market for obesity treatments by broadening access and reducing costs, experts said. Euronews · Dec 23, 2025
FDA approves Wegovy weight-loss pill in first green-lit alternative to injectable GLP-1 drugs U.S. regulators have approved a pill version of the weight-loss drug Wegovy, a boon for drugmaker Novo Nordisk The Independent UK · Dec 23, 2025
India’s doctors sound alarm over boom in availability of weight loss jabs Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk The Guardian - UK · Dec 20, 2025
Pfizer Adds to Its Big Bet on Weight Loss Drugs A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill. MarketBeat · Dec 16, 2025
A better Ozempic? Eli Lilly’s new obesity drug cut weight by 23%, study finds In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic knee pain after 68 weeks The Independent UK · Dec 11, 2025
Eli Lilly CEO David Ricks Unveils $6B Alabama Plant to Produce New Obesity Pill Eli Lilly CEO David Ricks has announced a new $6 billion manufacturing plant in Alabama dedicated to producing the company's next-generation obesity pill. The move signals Lilly's aggressive expansion as global demand for weight-loss drugs soars. International Business Times UK · Dec 10, 2025
“The Mounjaro Effect”: 40 Mounjaro Users Share Their Weight Loss Journeys We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who struggle with obesity often have trouble with their self-esteem, body image, anxiety, and depression. Nowadays, weight loss medications like Ozempic and Mounjaro might make their weight loss journeys… Bored Panda · Dec 10, 2025
The Independent UK · Dec 9, 2025 Weight-loss jabs could have hidden benefit for breast cancer patients Researchers found a link between the hormone estrone and breast cancer deaths in postmenopausal women
Benzinga · Dec 8, 2025 Wave Life Sciences One-Shot Obesity Drug Slashes Dangerous Visceral Fat Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.
The Independent UK · Dec 8, 2025 The generation ‘at risk of being left behind’ amid mental health and obesity crisis They are ‘struggling’ to access support as funding hasn’t kept up with demand
International Business Times UK · Dec 5, 2025 Ozempic on Cats? Updates on Biopharmaceutical Company Launches Pilot Study of GLP-1 Drug in Obese Cats An Ozempic-like drug implant might be available for your pets soon. Okava Pharma's GLP-1 implant pilot for obese cats (MEOW-1) aims to combat feline obesity, with due results in 2026.
Benzinga · Dec 4, 2025 What's Up With The Jump In Viking Therapeutics Stock? Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biopharmaceutical company seems to be benefitting from wider excitement in the obesity treatment area, as well as recent positive momentum after major clinical trial developments.
Evening Standard · Dec 4, 2025 Weight loss drugs for pets: Everything you need to know Okava Pharmaceuticals, a biopharmaceutical company, has launched a pilot study of a GLP-1 drug for cats with obesity
The Independent UK · Dec 4, 2025 Scientists find new link between obesity risk and the quality of your marriage The love hormone, oxytocin, may be able to influence our relationship with food, researchers say
The Guardian - UK · Dec 4, 2025 Parents and young people: share your concerns about ultra-processed foods (UPFs) We’re particularly interested in hearing from parents in low- and middle-income countries where the rise in childhood obesity is steepest
The Independent UK · Dec 3, 2025 Weight loss jabs can cut sick days in half, new research finds Weight loss jabs could keep people in work, according to a study of 700 NHS patients
The Independent UK · Dec 2, 2025 The common pre-teen habit that could be fuelling obesity A study of more than 10,000 12-year-olds found the earlier children acquired smartphones, the greater the risk of obesity, poor sleep, and depression
Euronews · Dec 2, 2025 Obesity may speed the onset of Alzheimer’s, scientists say A small study indicates regular blood tests could be a useful addition to brain scans that track the progression of Alzheimer’s disease.